Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer-Reference-Cited by-同舟云学术

Clinical and psychometric validation of an EORTC questionnaire module, the EORTC QLQ-OES18, to assess quality of life in patients with oesophageal cancer

Published:2003-07 Issue:10 Volume:39 Page:1384-1394
ISSN:0959-8049
Container-title:European Journal of Cancer
language:en
Short-container-title:European Journal of Cancer

Author:

Blazeby J.M,Conroy T,Hammerlid E,Fayers P,Sezer O,Koller M,Arraras J,Bottomley A,Vickery C.W,Etienne P.L,Alderson D

Publisher

Elsevier BV

Subject

Cancer Research,Oncology

Reference28 articles.

1. Oesophageal cancer;Akiyama;Curr. Probl. Surg.,1997

2. Extended transthoracic resection compared with limited transhiatal resection for adenocarcinoma of the esophagus;Hulscher;N. Engl. J. Med.,2002

3. Combined chemotherapy and radiotherapy compared with radiotherapy alone in patients with cancer of the oesophagus;Herskovic;N. Engl. J. Med.,1992

4. Chemotherapy followed by surgery compared with surgery alone for localised oesophageal cancer;Kelsen;N. Engl. J. Med.,1998

5. Randomized trial of preoperative chemoradiation versus surgery alone in patients with locoregional esophageal carcinoma;Urba;J. Clin. Oncol.,2001

Cited by 338 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preoperative administration of camrelizumab combined with chemotherapy for borderline resectable esophageal squamous cell carcinoma (BRES-1): study protocol of a single-arm, open-label, phase II study;Journal of Thoracic Disease;2024-07

2. Disease‐specific health‐related quality of life trajectories up to 15 years after curative treatment for esophageal cancer—a prospective cohort study;Cancer Medicine;2024-07

3. Development and validation of a novel Barrett's oesophagus patient reported outcome measure (B-PROM);eClinicalMedicine;2024-06

4. Effects of sintilimab plus chemotherapy as first-line treatment on health-related quality of life in patients with advanced esophageal squamous cell carcinoma: results from the randomized phase 3 ORIENT-15 study;eClinicalMedicine;2024-06